Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma

(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on...

Xcopri (cenobamate) Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube

 SK Life Science, Inc., a U.S. pharmaceutical company developing treatments that will change the future of central nervous system (CNS) disorders...

TLX101-CDx (Pixclara) Granted FDA Fast Track Designation

 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s...

2011 to 2020 Saw Increase in Annual Prescription Meds Expenditures

From 2011 to 2020, there was an increase in total annual prescription medication expenditures, with antimetabolic agents the most costly category, according...

Childhood Cancer Survivors Face Socioeconomic Difficulties

Childhood cancer survivors face socioeconomic difficulties, according to a review published online April 15 in JAMA Pediatrics.Márk Viktor Hernádfői,...

2011 to 2021 Saw Increase in Vaccination Timeliness for Infants

From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...

In-Hospital Mortality Rare After Percutaneous Coronary Intervention

In-hospital mortality is rare after percutaneous coronary intervention (PCI) and is most commonly related to prior cardiovascular condition, according...

The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)

NovelMed today announced that the Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to NM5072, an Alternative Pathway (AP)...

Antibiotics Probably Won't Ease Your Cough, Even If Infection is Bacterial: Study

Doctors sometimes prescribe antibiotics to help treat a cough, but a new study shows the drugs won’t help reduce the severity or duration of coughing...

Exercise Could Help Your Heart by Calming the Brain: Study

You know exercise is great for your cardiovascular health, but new research suggests that your brain has a lot to do with it. It's all about physical...

Researchers Probe Moments of Lucid Clarity Among People With Advanced Dementias

Lucid episodes are an unexpected occurrence among people with late-stage Alzheimer’s disease and related dementias. But these spontaneous events...

One in 3 Women With Migraines Say Attacks Occur During Periods

Among U.S. women with migraine, a third say the attacks tend to coincide with their periods, a new survey finds. Migraines that occur during menstruation...

Tips To Getting Your Rosacea Under Control

Rosacea is a common skin condition that causes redness on a person’s face. It commonly appears as a tendency to blush or flush more easily, but...

Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify (aripiprazole) Tablets Due to Drug Product Cross-Contamination on Manufacturing Equipment

PRINCETON, N.J. (April 9, 2024) – Otsuka America Pharmaceutical, Inc. (Otsuka) is voluntarily recalling certain Abilify (aripiprazole) Tablets in...

Read more news...

Recently Added

Recently added consumer and prescribing information: Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Zevtera Zevtera (ceftobiprole medocaril) is a cephalosporin antibiotic for the treatment of bacteremia, acute bacterial skin and skin structure...
  • Risvan Risvan (risperidone) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults.
  • Voydeya Voydeya (danicopan) is a complement factor D inhibitor used for the treatment of extravascular hemolysis in adults with paroxysmal...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development